In recent years, the chaos in the "health care" market has sounded the alarm for the health food industry, and the industry has fallen into a crisis of trust. Under the strict rectification of the "Hundred Days Action", non-standard enterprises are gradually eliminated by the market. With the rapid development of society and economy, the guidance of the "Healthy China 2030" policy, the improvement of people's living standards and the enhancement of health awareness, the demand for health food consumption has increased substantially, leaving a huge market development space for compliant companies.
Persist in the modern development of traditional Chinese medicine and build a guaranteed quality system
Standing at the forefront of industry development, Zhongke Health Industry Group will look at the 2021 as the "Product Quality Year".
Different from general health food companies, since its establishment in 1984, Zhongke Group has adhered to the modernisation of traditional Chinese medicine as its strategic development direction. Inheriting the original advantages of traditional Chinese medicine, on the basis of pharmacodynamics, pharmacology, and toxicology, the effective ingredients are extracted and concentrated to achieve safety and standardization, and a road to modernization of traditional Chinese medicine has been embarked on.
Driven by technological innovation, Zhongke Group continues to deepen its independent research and development of core technologies in the field of Ganoderma lucidum, and continues to increase R&D investment. With "normal temperature and constant temperature physical wall breaking technology", it has achieved high wall-breaking rate of Ganoderma lucidum spore powder. It is the first in the industry to invent Ganoderma lucidum spore oil with "CO2 supercritical extraction technology". Since 2006, Zhongke Group has initiated clinical research on the effective ingredients of Ganoderma lucidum, and has reached long-term and in-depth clinical cooperation with Guanganmen Hospital, MSK and other domestic and foreign hospitals to ensure continuous improvement of product quality with comprehensive, rigorous and reproducible experimental data. .
Supported by original scientific research results, China Science and Technology Group has obtained 67 health food certificates approved by the state, 2 new Chinese medicine certificates, and 2 new Chinese medicine clinical approvals. A total of 148 national patents have been authorized in history.
Based on product quality, stick to the quality line of defence. From the entire production and operation chain of product research and development, strain selection, raw material procurement, base production, quality inspection, sales service, etc., Zhongke strictly implements every process and comprehensively improves the quality management system.
The raw materials directly affect the quality of the product. Zhongke Group has established raw material supply bases in Israel, the United States, Canada and other places, selects natural raw materials and medicinal materials on a global scale, and builds a global raw material supply system.
It has a production base that meets GMP standards-Nanjing Zhongke Pharmaceutical, with a construction area of 38,000 square meters, and is a national high-tech enterprise. Realize production automation, standardization and industrialization throughout the process. The process and equipment of Chinese medicine extraction and other links are continuously upgraded, and the production process parameters have been scientifically, strictly and accurately monitored and controlled, which significantly improves the consistency of product batches and effectively guarantees product quality and stability. The planned construction of the Jiangsu Zhongke Pharmaceutical production base for the extraction of Chinese medicines also provides support for the establishment of a guaranteed quality system.
Quality inspection is the key to the quality management system. The China Science Testing Center is equipped with international advanced level analytical equipment such as gas chromatography-mass spectrometry (GC-MS) and high performance liquid chromatography. The quality inspection experiment team can undertake the inspection of the functional ingredients, moisture, ash, pesticide residues, plasticizers, heavy metals, microorganisms and other indicators from raw materials to finished products. Corresponding exploration and research on the iconic components of Chinese medicinal materials and plant materials. There are more than 30 internal control testing items for a single product, and the internal control standards are even higher than the national standards. From raw materials to production, each link is controlled layer by layer, and all finished products can only be produced and sold after passing the test. Establish a product traceability system, implement effective control over the product process, and escort product safety.
Make sure you know where you're buying your product from, we lead the global market with our range of Health supplements Since 1984.
Our investments in 2020 for new technology and extraction Technology have reached the amount of $20 Million USD.
The choice is yours!!!!